Target Name: C8orf76
NCBI ID: G84933
Review Report on C8orf76 Target / Biomarker Content of Review Report on C8orf76 Target / Biomarker
C8orf76
Other Name(s): Uncharacterized protein C8orf76 | CH076_HUMAN | chromosome 8 open reading frame 76 | Chromosome 8 open reading frame 76 | FLJ14825

Unraveling the Potential Drug Target and Biomarker C8orf76: A protein for the Treatment of Genetic Disorders

Introduction

C8orf76 is a protein that has garnered significant attention in recent years due to its association with a range of genetic disorders. The protein, named after its position in the C8 gene cluster on chromosome 8, has been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative disorders, and developmental defects. Although the exact function of C8orf76 in these processes remains unclear, research has identified several potential drug targets and biomarkers that may help to reveal its true role in human health. In In this article, we will explore the C8orf76 protein, its potential drug targets, and its potential as a biomarker for the diagnosis and treatment of genetic disorders.

The C8orf76 Protein

C8orf76 is a 21-kDa protein that is expressed in most tissues and cells in the human body. It is composed of 154 amino acid residues and has a calculated pI of 2.97 (pI is the protein's isoelectric point, a measure of its ability to dissolve in an ionic solution). C8orf76 is primarily localized to the endoplasmic reticulum (ER) and is also found in the cytoplasm.

Function and Association with Genetic Disorders

Several studies have demonstrated that C8orf76 is involved in the development and progression of various genetic disorders. For example, research has shown that C8orf76 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, C8orf76 has been implicated in the development of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases, as well as developmental defects, such as Down syndrome and Fragile X syndrome.

Potential Drug Targets

C8orf76 has several potential drug targets due to its involvement in the development and progression of various genetic disorders. Some of the most promising targets include:

1. Neuronal Communication: C8orf76 has been shown to play a role in the regulation of neuronal communication, which is critical for the development and progression of neurodegenerative disorders. Researchers are investigating the potential anti-neuronal communication drugs to interfere with the function of C8orf76.

2. Cellular Signaling: C8orf76 is involved in several cellular signaling pathways that are critical for the development and progression of various diseases. For example, it has been shown to be involved in the TGF-β pathway, which is involved in the development of cancer and other diseases.

3. inflammation: C8orf76 has been shown to play a role in the regulation of inflammation, which is a key aspect of the development and progression of many diseases, including neurodegenerative disorders.

Potential Biomarkers

C8orf76 has also been shown to be a potential biomarker for the diagnosis and treatment of various genetic disorders. Its association with the development and progression of various diseases makes it an attractive candidate for diagnostic tests and potential therapeutic interventions. For example, C8orf76 has been shown to be highly expressed in the brains of individuals with Down syndrome, a genetic disorder that is characterized by mental retardation, movement disorders and changes in facial features. Additionally, C8orf76 has been shown to be highly expressed in the brains of individuals with Fragile X syndrome, a genetic disorder that is characterized by motor neuron dysfunction and cognitive impairments.

Conclusion

In conclusion, C8orf76 is a protein that has significant involvement in the development and progression of various genetic disorders. Its potential drug targets and biomarker status make it an attractive candidate for the development of new treatments for these disorders. Further research is needed to fully understand the role of C8orf76 in human health and to explore its potential as a

Protein Name: Chromosome 8 Open Reading Frame 76

The "C8orf76 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C8orf76 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C8orf82 | C8orf88 | C8orf89 | C9 | C9orf131 | C9orf152 | C9orf153 | C9orf163 | C9orf24 | C9orf40 | C9orf43 | C9orf47 | C9orf50 | C9orf57 | C9orf64 | C9orf72 | C9orf78 | C9orf78P2 | C9orf85 | CA1 | CA10 | CA11 | CA12 | CA13 | CA14 | CA15P1 | CA2 | CA3 | CA3-AS1 | CA4 | CA5A | CA5B | CA5BP1 | CA6 | CA7 | CA8 | CA9 | CAAP1 | CAB39 | CAB39L | CABCOCO1 | CABIN1 | CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1